Try our Advanced Search for more refined results

In Re: Testosterone Replacement Therapy Products Liability Litigation

Track this case

Case overview

Case Number:

1:14-cv-01748

Court:

Illinois Northern

Nature of Suit:

367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)

Judge:

Honorable Matthew F. Kennelly

Firms

Companies

Government Agencies

Sectors & Industries:

  1. May 30, 2017

    AbbVie Fights Evidence Ahead Of Testosterone Bellwether

    As a first bellwether trial over the alleged health risks of testosterone therapy AndroGel approaches, drugmaker AbbVie and consumers agree that the trial shouldn't be split into two phases, but AbbVie asked an Illinois federal judge Monday to reject evidence related to its alleged misconduct.

  2. May 08, 2017

    AbbVie Can't Dodge Consumers' Claims In Testosterone MDL

    AbbVie Inc. and Abbott Laboratories must face the bulk of claims brought by seven people whose cases were selected for bellwether trials in multidistrict litigation over the safety of testosterone gel products, an Illinois federal judge ruled Monday.

  3. February 22, 2017

    AbbVie Wants Out Of Testosterone MDL Before Bellwethers

    AbbVie Inc. and Abbott Laboratories have asked an Illinois federal judge to let them out of a massive multidistrict litigation over the marketing and sale of testosterone gel products, arguing the consumers haven’t shown a connection between the drug and the alleged increased risk of heart attack and stroke.

  4. February 09, 2017

    AbbVie Fights Discovery Request Of Doc In Testosterone MDL

    AbbVie Inc. told an Illinois federal judge on Wednesday that a discovery request for information from a doctor serving as an expert witness went beyond what was proper in the multidistrict litigation over heart health risks and injuries allegedly caused by testosterone replacement therapy drugs.

  5. January 03, 2017

    AbbVie Can't Trim Report In Testosterone Replacement MDL

    An Illinois federal judge overseeing multidistrict litigation over heart health risks and injuries allegedly caused by testosterone replacement therapy drugs refused Tuesday to trim an expert report that supports claims against drugmaker AbbVie Inc.

  6. October 11, 2016

    Besin Denied Quick Exit In Testosterone Replacement MDL

    An Illinois federal judge overseeing multidistrict litigation over heart health risks and injuries allegedly caused by testosterone replacement therapy drugs refused Monday to toss claims against Belgian drug manufacturer Besins Healthcare, saying consumers have convincingly shown the pharmaceutical company sells enough of its product in the U.S. to remain in the litigation.

  7. March 08, 2016

    Some Fraud Claims Resurrected In Testosterone MDL

    An Illinois federal judge has brought back half a lawsuit filed by consumers who say drugmakers didn’t warn about health problems linked to certain generic testosterone replacement therapy drugs, saying that he’d erred in ruling that some allegations were preempted by federal law.

  8. December 22, 2015

    Consumers Seek To Pause Pfizer Exit From Testosterone Suit

    Consumers claiming pharmaceutical companies failed to warn about heart problems linked to certain testosterone replacement drugs urged an Illinois federal judge Tuesday to hold off on dismissing Pfizer and an Endo unit from multidistrict litigation, arguing they should be allowed to examine evidence that the U.S. Food and Drug Administration permitted the companies to update their drug labels.

  9. November 12, 2015

    Pfizer, Endo Unit Duck MDL Claims Over Testosterone Drugs

    An Illinois federal judge overseeing multidistrict litigation over heart health risks and injuries allegedly caused by testosterone drugs made by Pfizer and an Endo unit has ruled the claims against them are preempted because the companies did not have the power to unilaterally strengthen their warnings.